Time on treatment of everolimus and chemotherapy among postmenopausal women with hormone-receptor-positive/human-epidermal-growth-factor-receptor-2-negative metastatic breast cancer: a retrospective claims study in the US. [electronic resource]
Producer: 20160829Description: 385-94 p. digitalISSN:- 1473-4877
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Breast Neoplasms -- drug therapy
- Capecitabine -- administration & dosage
- Everolimus -- administration & dosage
- Female
- Humans
- Kaplan-Meier Estimate
- Middle Aged
- Postmenopause
- Proportional Hazards Models
- Receptor, ErbB-2
- Retrospective Studies
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.